Foxo Technologies Inc
AMEX:FOXO
FOXO's latest stock split occurred on Apr 29, 2025
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, FOXO traded at 0.084 per share. Afterward, the share price was about 0.9451.
The adjusted shares began trading on Apr 29, 2025. This was FOXO's 2nd stock split, following the previous one in Nov 7, 2023.
88EDA
SBET
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
You don't have any saved screeners yet